Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Swissmedic approves BTG's DigiFab for life-threatening digitalis intoxication

Feb. 5, 2010

Oxytocin attenuates methamphetamine self-administration in rats

Feb. 4, 2010

Beta-lactam antibiotic ceftriaxone reduces cocaine-seeking behavior in rats

Jan. 28, 2010

Preliminary trial supports use of dextroamphetamine for methamphetamine addiction

Jan. 28, 2010

Cleveland BioLabs initiates dosing in phase Ib trial of CBLB-502

Jan. 21, 2010

Aeolus invited to submit full proposal to BARDA for further development AEOL-10150

Jan. 18, 2010

Kappa-opioid receptor antagonists claimed by Janssen for treatment of addiction

Dec. 29, 2009

Cleveland BioLabs initiates enrollment in safety study of CBLB-502 for ARS

Nov. 27, 2009

Alkermes initiates phase II trial of ALKS-33 for alcohol dependence

Nov. 19, 2009

Naltrexone implant shown to be safe and effective in heroin dependence

Nov. 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...